8-K: USANA Health Sciences Reports Q2 Loss, Cuts Full-Year Outlook

USANA Health Sciences announced a second-quarter net loss of $21.4 million and reduced its fiscal year 2026 guidance, citing underperformance in its ventures businesses.

Summary

• USANA Health Sciences reported a net loss of $21.4 million for the second quarter ended July 4, 2026, compared to a net earning of $9.7 million in the prior year's quarter.
• The company's net sales decreased by 5% year-over-year to $223 million.
• Adjusted diluted EPS was $(0.07) for the quarter, down from $0.74 in Q2 2025.
• Adjusted EBITDA was $27.8 million, a decrease from $30.5 million in the prior year.
• Core Nutritional active customers decreased by 8% to 384,000, and Hiya active monthly subscribers fell by 17% to 166,000.
• The company has updated its fiscal year 2026 outlook, projecting a net loss of $(11) million and consolidated net sales of $910 million, both lower than previous expectations.
• A significant factor in the net loss was a preliminary non-cash impairment charge of $29.1 million related to goodwill for the Hiya reporting unit.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to declining sales, net loss, and reduced forward guidance, despite efforts to diversify.

Positives

• The Core Nutritional business performed generally in line with expectations, with net sales of $192 million.
• Mainland China, the largest market, showed modest year-over-year net sales growth for the second consecutive quarter.
• USANA launched 'Glow,' a new skin-health supplement, which was well-received.
• The company ended the quarter with $169 million in cash and zero debt.
• Inventories decreased by 12% to $95 million.
• Free cash flow of $20 million was generated in the quarter due to improved working capital management.
• Hiya's gross margins increased by 410 basis points year-over-year to 67.9%.

Negatives

• Net sales declined 5% year-over-year to $223 million.
• The company reported a net loss of $21.4 million, compared to a net profit of $9.7 million in the prior year.
• Diluted EPS was $(1.16), a significant drop from $0.52 in Q2 2025.
• Adjusted diluted EPS was $(0.07), down from $0.74.
• Core Nutritional active customers decreased by 8% to 384,000.
• Hiya active monthly subscribers decreased by 17% to 166,000.
• A $29.1 million non-cash impairment charge was recorded for Hiya's goodwill.
• The fiscal year 2026 outlook was significantly lowered, projecting a net loss and reduced consolidated net sales.

Risks

• Challenging digital marketing environment impacting Hiya's subscriber growth and margins.
• Packaging-related disruption affected Rise Wellness's commercial execution.
• Reliance on Brand Partners and potential issues with the compensation plan.
• Risks associated with new product launches or reformulations.
• Governmental regulation of products, manufacturing, and direct selling business models.
• Potential negative effects of deteriorating foreign and/or trade relations, particularly between the US and China.
• Geopolitical relations and conflicts impacting global markets.
• Uncertainty related to currency fluctuations.

Future Outlook

The company has updated its fiscal year 2026 outlook, now projecting consolidated net sales of $910 million, a net loss of $(11) million, and adjusted diluted EPS of $0.76. This revised outlook reflects lower-than-anticipated net sales and operating margins for Hiya and Rise Wellness.

Management Comments

• "Our consolidated second quarter results reflect mixed performance as the Core Nutritional business delivered results generally in line with our expectations, while our ventures businesses performed below expectations."
• "Hiya continued to experience a challenging digital marketing environment, which pressured topline performance, subscriber growth, and margins."
• "While we believe that these challenges for Hiya and Rise are temporary, and both companies remain well positioned to execute their growth strategies, we now expect net sales for these businesses during the full year to be below our prior expectations and are updating our outlook accordingly."
• "We remain confident in USANA's strategic transformation from a single-channel direct sales business into a diversified, omnichannel health and wellness company built on consumer acquisition and loyalty."
• "Our balance sheet continues to be a source of strength, as we ended the period with $169 million in cash and debt-free. We also generated $20 million in free cash flow this quarter, driven in large part by improved working capital management."

Industry Context

StockSavvy.ai notes that the challenges faced by USANA in its ventures businesses (Hiya and Rise Wellness) reflect broader industry trends in the direct-to-consumer (DTC) space, particularly the increasing cost and difficulty of digital customer acquisition due to a competitive and evolving marketing landscape.

Stakeholder Impact

• Shareholders: Negative impact due to net loss, reduced EPS, and lowered future guidance, likely affecting stock price.
• Brand Partners: Potential concern over business performance, though management is focused on evolving incentive plans and driving engagement.
• Customers: Continued access to Core Nutritional products; Hiya and Rise Wellness products may face supply or availability challenges due to business performance issues.
• Suppliers: Potential for reduced orders from Hiya and Rise Wellness due to lower sales forecasts.

Next Steps

• Continue to evolve the Brand Partner incentive plan.
• Accelerate product innovation.
• Modernize technology infrastructure.
• Host the Live 2026 Americas Convention in San Diego.
• Expand Hiya's presence in additional retail accounts, including club retail and Amazon.
• Deepen Hiya's footprint in Canada and the UK through localized marketing and retail development.
• Rise Wellness plans to launch an additional product in the third quarter.
• Pursue new distribution opportunities for Rise Wellness across grocery and specialty retail partners.

Key Dates

Recommendation

While the Q2 results and revised outlook are negative, the company maintains a strong balance sheet with significant cash and no debt. The Core Nutritional business remains stable, and management is actively pursuing a strategic transformation. However, the underperformance of ventures businesses and the goodwill impairment warrant caution, suggesting a 'hold' until there is clearer evidence of a turnaround and successful execution of the omnichannel strategy.

Keywords

health and wellness, nutritional supplements, direct sales, omnichannel, financial results, earnings, guidance, impairment charge